291 related articles for article (PubMed ID: 7013458)
21. Prazosin and captopril in chronic heart failure: comparison of acute haemodynamic and hormonal effects.
Sharpe DN; Coxon R
Aust N Z J Med; 1982 Oct; 12(5):483-8. PubMed ID: 6758746
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of captopril in low-renin congestive heart failure: importance of sustained reactive hyperreninemia in distinguishing responders from nonresponders.
Packer M; Medina N; Yushak M
Am J Cardiol; 1984 Oct; 54(7):771-7. PubMed ID: 6091434
[TBL] [Abstract][Full Text] [Related]
23. Endogenous prostaglandin E2 metabolite levels, renin-angiotensin system and catecholamines versus acute hemodynamic response to captopril in chronic congestive heart failure.
Silberbauer K; Punzengruber C; Sinzinger H
Cardiology; 1983; 70(6):297-307. PubMed ID: 6370431
[TBL] [Abstract][Full Text] [Related]
24. Hemodynamic effects of captropril in chronic heart failure: efficacy of low-dose treatment and comparison with prazosin.
Sharpe DN; Coxon R
Am Heart J; 1982 Nov; 104(5 Pt 2):1164-71. PubMed ID: 6291361
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin II levels, hemodynamics, and sympathoadrenal function after low-dose captopril in heart failure.
Cleland J; Semple P; Hodsman P; Ball S; Ford I; Dargie H
Am J Med; 1984 Nov; 77(5):880-6. PubMed ID: 6388325
[TBL] [Abstract][Full Text] [Related]
26. Effects of converting-enzyme inhibition on cardiorenal hemodynamics in patients with chronic congestive heart failure.
Kubo S; Nishioka A; Nishimura H; Kawamura K; Takatsu T
J Cardiovasc Pharmacol; 1985; 7(4):753-9. PubMed ID: 2410718
[TBL] [Abstract][Full Text] [Related]
27. Sustained haemodynamic and clinical effects of captopril in long-term treatment of severe chronic congestive heart failure.
Ricci S; Zaniol P; Teglio V; Baraldi P; Mattioli G
Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):209S-215S. PubMed ID: 6291564
[TBL] [Abstract][Full Text] [Related]
28. Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure.
Levine TB; Franciosa JA; Cohn JN
Circulation; 1980 Jul; 62(1):35-41. PubMed ID: 6247102
[No Abstract] [Full Text] [Related]
29. Efficacy of oral angiotensin-converting enzyme inhibition with captopril therapy in severe chronic normotensive congestive heart failure.
Awan NA; Evenson MK; Needham KE; Win A; Mason DT
Am Heart J; 1981 Jan; 101(1):22-31. PubMed ID: 6257100
[TBL] [Abstract][Full Text] [Related]
30. Long-term control of congestive heart failure with captopril.
Fouad FM; Tarazi RC; Bravo EL; Hart NJ; Castle LW; Salcedo EE
Am J Cardiol; 1982 Apr; 49(6):1489-96. PubMed ID: 6803563
[TBL] [Abstract][Full Text] [Related]
31. Peripheral haemodynamic effects of inhibition of prostaglandin synthesis in congestive heart failure and interactions with captopril.
Townend JN; Doran J; Lote CJ; Davies MK
Br Heart J; 1995 May; 73(5):434-41. PubMed ID: 7786658
[TBL] [Abstract][Full Text] [Related]
32. Role of the renin-angiotensin system in the development of congestive heart failure in the dog as assessed by chronic converting-enzyme blockade.
Riegger GA; Liebau G; Holzschuh M; Witkowski D; Steilner H; Kochsiek K
Am J Cardiol; 1984 Feb; 53(4):614-8. PubMed ID: 6320625
[TBL] [Abstract][Full Text] [Related]
33. Haemodynamic, hormonal, and electrolyte responses to captopril in resistant heart failure.
Maslowski AH; Ikram H; Nicholls MG; Espiner EA
Lancet; 1981 Jan; 1(8211):71-4. PubMed ID: 6109121
[TBL] [Abstract][Full Text] [Related]
34. Effect of angiotensin converting enzyme inhibition on plasma endothelin in congestive heart failure.
Townend J; Doran J; Jones S; Davies M
Int J Cardiol; 1994 Mar; 43(3):299-304. PubMed ID: 8181887
[TBL] [Abstract][Full Text] [Related]
35. [The effect of bunazosin vs captopril on hemodynamic and neurohumoral parameters in patients with congestive heart failure].
Kawahara Y; Hasegawa K; Sawayama T; Inoue S; Nakamura T; Kakumae S; Tadaoka S; Nakao M; Nezuo S
Kokyu To Junkan; 1989 Dec; 37(12):1333-40. PubMed ID: 2575781
[TBL] [Abstract][Full Text] [Related]
36. Hemodynamic and hormonal responses during captopril therapy for heart failure: acute, chronic and withdrawal studies.
Nicholls MG; Ikram H; Espiner EA; Maslowski AH; Scandrett MS; Penman T
Am J Cardiol; 1982 Apr; 49(6):1497-501. PubMed ID: 6803564
[TBL] [Abstract][Full Text] [Related]
37. Comparative immediate hemodynamic and hormonal effects of amrinone and captopril in patients with severe chronic heart failure.
Packer M; Medina N; Yushak M
Am J Med Sci; 1986 Jan; 291(1):8-15. PubMed ID: 3510545
[TBL] [Abstract][Full Text] [Related]
38. Effects of a single administration of captopril on hemodynamics and serum angiotensin converting enzyme activity, plasma renin activity and plasma aldosterone concentration in hypertensive patients.
Hashimoto H; Hiwada K; Kokubu T
Jpn Circ J; 1981 Feb; 45(2):176-80. PubMed ID: 6262543
[TBL] [Abstract][Full Text] [Related]
39. Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure.
Halperin JL; Faxon DP; Creager MA; Bass TA; Melidossian CD; Gavras H; Ryan TJ
Am J Cardiol; 1982 Nov; 50(5):967-72. PubMed ID: 6182786
[TBL] [Abstract][Full Text] [Related]
40. Angiotensin-converting enzyme inhibition, catecholamines and hemodynamics in essential hypertension.
Muiesan G; Alicandri CL; Agabiti-Rosei E; Fariello R; Beschi M; Boni E; Castellano M; Moniti E; Muiesan L; Romanelli G; Zanielli A
Am J Cardiol; 1982 Apr; 49(6):1420-4. PubMed ID: 6280474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
